Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate a Single IM Dose of Motavizumab Treatment of Children With RSV (Respiratory Syncytial Virus) Illness

This study has been completed.
Information provided by:
MedImmune LLC Identifier:
First received: February 13, 2007
Last updated: July 2, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 2, 2012